(Circulation. 2005;111:1071-1077.)
© 2005 American Heart Association, Inc.
Vascular Medicine |
From the Cardiovascular Research Institute, Morehouse School of Medicine, Atlanta, Ga (M.F., J.Z., T.C., Y.X., Y.M., H.D.L., Y.E.C.); Research Division, Joslin Diabetes Center, Department of Medicine, Harvard Medical School, Boston, Mass (Y.-H.T., C.R.K.); Cardiovascular Research Institute, Peking University Health Science Center, Beijing, China (X.Z.); Center for Comparative Respiratory Biology and Medicine, School of Medicine, University of California, Davis (M.M.J.C.); and Center for Cardiovascular Development, Department of Medicine, Baylor College of Medicine, Houston, Tex (Y.H.). Dr Fu is now at the Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas.
Correspondence to Dr Y.E. Chen, Cardiovascular Research Institute, Morehouse School of Medicine, 720 Westview Dr SW, Atlanta, GA 30310. E-mail echen{at}msm.edu
Received July 13, 2004; revision received October 3, 2004; accepted November 2, 2004.
Background Rad (Ras associated with diabetes) GTPase is a prototypic member of a new subfamily of Ras-related GTPases with unique structural features, although its physiological role remains largely unknown. In the present study, we characterized the Rad function in vascular smooth muscle cells (VSMCs) and the influence of adenovirus-mediated Rad (Ad-Rad) gene delivery on vascular remodeling after experimental angioplasty.
Methods and Results We documented for the first time that neointimal formation using balloon-injured rat carotid arteries was associated with a significant increase in Rad expression as determined by immunohistochemistry and quantitative real-time reverse-transcriptase polymerase chain reaction. The levels of Rad expression in VSMCs were highly induced by platelet-derived growth factor and tumor necrosis factor-
. Morphometric analyses 14 days after injury revealed significantly diminished neointimal formation in the Ad-Radtreated carotid arteries compared with Ad-GFP or PBS controls, whereas the mutated form of Rad GTPase, which can bind GDP but not GTP, increased neointimal formation. Overexpression of Rad significantly inhibited the attachment and migration of VSMCs. In addition, Rad expression dramatically reduced the formation of focal contacts and stress fibers in VSMCs by blocking the Rho/ROK signaling pathway.
Conclusions Our data clearly identified Rad GTPase as a novel and critical mediator that inhibits vascular lesion formation. Manipulation of the Rad signaling pathway may provide new therapeutic approaches that will limit vascular pathological remodeling.
Key Words: atherosclerosis cell movement cells, vascular smooth muscle monomeric GTP-binding proteins restenosis
This article has been cited by other articles:
![]() |
L. Chang, J. Zhang, Y.-H. Tseng, C.-Q. Xie, J. Ilany, J. C. Bruning, Z. Sun, X. Zhu, T. Cui, K. A. Youker, et al. Rad GTPase Deficiency Leads to Cardiac Hypertrophy Circulation, December 18, 2007; 116(25): 2976 - 2983. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yada, M. Murata, K. Shimoda, S. Yuasa, H. Kawaguchi, M. Ieda, T. Adachi, M. Murata, S. Ogawa, and K. Fukuda Dominant Negative Suppression of Rad Leads to QT Prolongation and Causes Ventricular Arrhythmias via Modulation of L-type Ca2+ Channels in the Heart Circ. Res., July 6, 2007; 101(1): 69 - 77. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Villacorta, J. Zhang, M. T. Garcia-Barrio, X.-l. Chen, B. A. Freeman, Y. E. Chen, and T. Cui Nitro-linoleic acid inhibits vascular smooth muscle cell proliferation via the Keap1/Nrf2 signaling pathway Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H770 - H776. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ilany, P. J. Bilan, S. Kapur, J. S. Caldwell, M.-E. Patti, A. Marette, and C. R. Kahn Overexpression of Rad in muscle worsens diet-induced insulin resistance and glucose intolerance and lowers plasma triglyceride level PNAS, March 21, 2006; 103(12): 4481 - 4486. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |